BIOMAT Database Logo BIOMAT Database Logo

Suppression of tumor growth and induction of specific tumor immunity by intradermal inoculation of a mixture of living tumor cells and live Mycobacterium bovis in syngeneic mice. 1971

T Tanaka, and T Tokunaga

UI MeSH Term Description Entries
D008748 Methylcholanthrene A carcinogen that is often used in experimental cancer studies. 20-Methylcholanthrene,3-Methylcholanthrene,20 Methylcholanthrene,3 Methylcholanthrene
D009163 Mycobacterium bovis The bovine variety of the tubercle bacillus. It is called also Mycobacterium tuberculosis var. bovis. BCG,Calmette-Guerin Bacillus
D009374 Neoplasms, Experimental Experimentally induced new abnormal growth of TISSUES in animals to provide models for studying human neoplasms. Experimental Neoplasms,Experimental Neoplasm,Neoplasm, Experimental
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012510 Sarcoma 180 An experimental sarcoma of mice. Sarcoma 180, Crocker,Crocker Sarcoma 180
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

T Tanaka, and T Tokunaga
Tumor immunity produced by the intradermal inoculation of living tumor cells and living Mycobacterium bovis (strain BCG).
December 1970, Science (New York, N.Y.),
T Tanaka, and T Tokunaga
Comparative effect of Mycobacterium bovis- and neuraminidase-treated tumor cells on the growth of established methylcholanthrene fibrosarcomas in syngeneic mice.
January 1972, Cancer research,
T Tanaka, and T Tokunaga
Induced resistance in normal mice and growth enhancement in tumor-bearing mice by inoculation with syngeneic hybrid cells.
October 1980, Journal of the National Cancer Institute,
T Tanaka, and T Tokunaga
Syngeneic tumor immunity induction in Swiss mice by Abrus agglutinin treated S-180 sarcoma cells.
September 1976, Taiwan yi xue hui za zhi. Journal of the Formosan Medical Association,
T Tanaka, and T Tokunaga
[Growth suppression of subcutaneous tumor by CT26 expressing NK4 in syngeneic mice].
November 2002, Gan to kagaku ryoho. Cancer & chemotherapy,
T Tanaka, and T Tokunaga
Relationship between intradermal tumor suppression and tumor immunity.
December 1976, Journal of the National Cancer Institute,
T Tanaka, and T Tokunaga
Induction of anti-tumor immunity in mice using a syngeneic endothelial cell vaccine.
January 2003, Anticancer research,
T Tanaka, and T Tokunaga
Tumor suppression by Mycobacterium bovis (strain BCG) enhanced by vitamin A.
August 1974, Journal of the National Cancer Institute,
T Tanaka, and T Tokunaga
Effects of PSK on specific tumor immunity to syngeneic tumor cells.
April 1983, Journal of clinical & laboratory immunology,
T Tanaka, and T Tokunaga
Augmented induction of tumor-specific resistance by priming with Mycobacterium tuberculosis (TBC) and subsequent immunization with PPD-coupled syngeneic tumor cells.
December 1980, Journal of immunology (Baltimore, Md. : 1950),
Copied contents to your clipboard!